Immunomodulatory drugs in sepsis: a systematic review and meta-analysis.

Autor: Robey RC; Division of Infection, Immunity and Respiratory Medicine, School of Biological Sciences, University of Manchester, Manchester Academic Health Science Centre, Manchester, UK.; Wythenshawe Hospital, Manchester University NHS Foundation Trust, Manchester, UK., Logue C; Wythenshawe Hospital, Manchester University NHS Foundation Trust, Manchester, UK., Caird CA; Wythenshawe Hospital, Manchester University NHS Foundation Trust, Manchester, UK., Hansel J; Division of Infection, Immunity and Respiratory Medicine, School of Biological Sciences, University of Manchester, Manchester Academic Health Science Centre, Manchester, UK.; Wythenshawe Hospital, Manchester University NHS Foundation Trust, Manchester, UK., Hellyer TP; Translational and Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, UK., Simpson J; Translational and Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, UK., Dark P; University of Manchester, Manchester Academic Health Science Centre, Manchester, UK.; Critical Care Unit, Northern Care Alliance NHS Foundation Trust, Salford Care Organisation, Salford, UK., Mathioudakis AG; Wythenshawe Hospital, Manchester University NHS Foundation Trust, Manchester, UK.; Division of Infection, Immunity and Respiratory Medicine, School of Biological Sciences, University of Manchester, Manchester Academic Health Science Centre, Manchester, UK., Felton T; Division of Infection, Immunity and Respiratory Medicine, School of Biological Sciences, University of Manchester, Manchester Academic Health Science Centre, Manchester, UK.; Wythenshawe Hospital, Manchester University NHS Foundation Trust, Manchester, UK.

Publikováno v: Anaesthesia [Anaesthesia] 2024 Aug; Vol. 79 (8), pp. 869-879. Date of Electronic Publication: 2024 Mar 24.

Clinical trials of pneumonia management assess heterogeneous outcomes and measurement instruments.

Autor: Mathioudakis AG; Division of Immunology, Immunity to Infection and Respiratory Medicine, School of Biological Sciences, The University of Manchester, Manchester, UK; North West Lung Centre, Wythenshawe Hospital, Manchester University NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK. Electronic address: alexander.mathioudakis@manchester.ac.uk., Fally M; Department of Respiratory Medicine and Infectious Diseases, Copenhagen University Hospital - Bispebjerg and Frederiksberg, Copenhagen, Denmark., Hansel J; Division of Immunology, Immunity to Infection and Respiratory Medicine, School of Biological Sciences, The University of Manchester, Manchester, UK; North West School of Intensive Care Medicine, Health Education England North West, Manchester, UK., Robey RC; Division of Immunology, Immunity to Infection and Respiratory Medicine, School of Biological Sciences, The University of Manchester, Manchester, UK; North West Lung Centre, Wythenshawe Hospital, Manchester University NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK., Haseeb F; Division of Immunology, Immunity to Infection and Respiratory Medicine, School of Biological Sciences, The University of Manchester, Manchester, UK., Williams T; Acute Intensive Care Unit, Wythenshawe Hospital, Manchester University NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK., Kouta A; Division of Immunology, Immunity to Infection and Respiratory Medicine, School of Biological Sciences, The University of Manchester, Manchester, UK., Welte T; Department of Respiratory Medicine and German Centre of Lung Research (DZL), Hannover Medical School, Hanover, Germany., Wootton DG; Institute of Infection, Veterinary and Ecological Sciences, NIHR HPRU in Emerging and Zoonotic Infections, University of Liverpool, Liverpool, UK., Clarke M; Centre of Public Health, School of Medicine, Dentistry and Biomedical Sciences, Queen's University Belfast, Belfast, UK., Waterer G; School of Medicine and Pharmacology, Royal Perth Hospital, University of Western Australia, Perth, Western Australia, Australia., Dark P; Division of Immunology, Immunity to Infection and Respiratory Medicine, School of Biological Sciences, The University of Manchester, Manchester, UK., Williamson PR; Department of Health Data Science, MRC/NIHR Trials Methodology Research Partnership, University of Liverpool, Liverpool, UK., Vestbo J; Division of Immunology, Immunity to Infection and Respiratory Medicine, School of Biological Sciences, The University of Manchester, Manchester, UK; North West Lung Centre, Wythenshawe Hospital, Manchester University NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK., Felton TW; Division of Immunology, Immunity to Infection and Respiratory Medicine, School of Biological Sciences, The University of Manchester, Manchester, UK; North West Lung Centre, Wythenshawe Hospital, Manchester University NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK; Acute Intensive Care Unit, Wythenshawe Hospital, Manchester University NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK.

Publikováno v: Journal of clinical epidemiology [J Clin Epidemiol] 2023 Dec; Vol. 164, pp. 88-95. Date of Electronic Publication: 2023 Oct 26.

Large scale clinical trials: lessons from the COVID-19 pandemic.

Autor: Horsley AR; Division of Infection, Immunity and Respiratory Medicine, The University of Manchester Faculty of Medical and Human Sciences, Manchester, UK alexander.horsley@manchester.ac.uk., Pearmain L; Division of Infection, Immunity and Respiratory Medicine, The University of Manchester Faculty of Medical and Human Sciences, Manchester, UK.; Division of Diabetes, Endocrinology and Gastroenterology, The University of Manchester Faculty of Biology Medicine and Health, Manchester, UK., Knight S; Division of Infection, Immunity and Respiratory Medicine, The University of Manchester Faculty of Medical and Human Sciences, Manchester, UK.; Department of Respiratory Medicine, Salford Royal NHS Foundation Trust, Salford, UK., Schindler N; Institute of Continuing Education, University of Cambridge, Cambridge, UK.; Department of Paediatrics, Norfolk and Norwich University Hospitals NHS Foundation Trust, Norwich, UK., Wang R; Division of Infection, Immunity and Respiratory Medicine, The University of Manchester Faculty of Medical and Human Sciences, Manchester, UK., Bennett M; Division of Infection, Immunity and Respiratory Medicine, The University of Manchester Faculty of Medical and Human Sciences, Manchester, UK., Robey RC; Division of Infection, Immunity and Respiratory Medicine, The University of Manchester Faculty of Medical and Human Sciences, Manchester, UK., Davies JC; National Heart & Lung Institute, Imperial College London, London, UK., Djukanović R; School of Clinical and Experimental Sciences, Faculty of Medicine, University of Southampton School of Medicine, Southampton, UK., Heaney LG; Centre of Infection and Immunity, Queen's University Belfast, Belfast, UK., Hussell T; Manchester Centre for Infection and Inflammation Research, The University of Manchester Faculty of Biology Medicine and Health, Manchester, UK., Marciniak SJ; Cambridge Institute for Medical Research, University of Cambridge, Cambridge, UK.; Royal Papworth Hospital NHS Foundation Trust, Cambridge, UK., McGarvey LP; Wellcome-Wolfson Institute for Experimental Medicine, Queen's University Belfast, Belfast, UK., Porter J; Centre for Inflammation & Tissue Repair, University College London Division of Medicine, London, UK.; Interstitial Lung Disease Service, University College London Hospitals NHS Foundation Trust, London, UK., Wilkinson T; Clinical and Experimental Medicine, University of Southampton School of Medicine, Southampton, UK., Brightling C; Institute of Lung Health, University of Leicester, Leicester, UK., Ho LP; MRC Human Immunology Unit, Weatherall Institute of Molecular Medicine, Oxford, UK.; Oxford Centre for Respiratory Medicine, Churchill Hospital, Oxford, UK.

Publikováno v: BMJ open respiratory research [BMJ Open Respir Res] 2022 Jun; Vol. 9 (1).

Pulmonary Sequelae at 4 Months After COVID-19 Infection: A Single-Centre Experience of a COVID Follow-Up Service.

Autor: Robey RC; Department of Respiratory Medicine, Wythenshawe Hospital, Manchester University NHS Foundation Trust, Manchester, UK. rebecca.robey@doctors.org.uk.; Division of Infection, Immunity and Respiratory Medicine, School of Biological Sciences, University of Manchester, Manchester, UK. rebecca.robey@doctors.org.uk., Kemp K; Department of Respiratory Medicine, Wythenshawe Hospital, Manchester University NHS Foundation Trust, Manchester, UK., Hayton P; Department of Respiratory Medicine, Wythenshawe Hospital, Manchester University NHS Foundation Trust, Manchester, UK., Mudawi D; Department of Respiratory Medicine, Wythenshawe Hospital, Manchester University NHS Foundation Trust, Manchester, UK., Wang R; Department of Respiratory Medicine, Wythenshawe Hospital, Manchester University NHS Foundation Trust, Manchester, UK.; Division of Infection, Immunity and Respiratory Medicine, School of Biological Sciences, University of Manchester, Manchester, UK.; Manchester Academic Health Science Centre and NIHR Manchester Biomedical Research Centre, Manchester University NHS Foundation Trust, Manchester, UK., Greaves M; Department of Radiology, Wythenshawe Hospital, Manchester University NHS Foundation Trust, Manchester, UK., Yioe V; Department of Respiratory Medicine, Wythenshawe Hospital, Manchester University NHS Foundation Trust, Manchester, UK., Rivera-Ortega P; Department of Respiratory Medicine, Wythenshawe Hospital, Manchester University NHS Foundation Trust, Manchester, UK., Avram C; Department of Respiratory Medicine, Wythenshawe Hospital, Manchester University NHS Foundation Trust, Manchester, UK., Chaudhuri N; Department of Respiratory Medicine, Wythenshawe Hospital, Manchester University NHS Foundation Trust, Manchester, UK.

Publikováno v: Advances in therapy [Adv Ther] 2021 Aug; Vol. 38 (8), pp. 4505-4519. Date of Electronic Publication: 2021 Jul 18.

Modulation of Early Host Innate Immune Response by an Avipox Vaccine Virus' Lateral Body Protein.

Autor: Giotis ES; Section of Virology, School of Medicine, St Mary's Campus, Imperial College, London W2 1PG, UK.; School of Life Sciences, University of Essex, Colchester C04 3SQ, UK., Laidlaw SM; Section of Virology, School of Medicine, St Mary's Campus, Imperial College, London W2 1PG, UK., Bidgood SR; Medical Research Council-Laboratory for Molecular Cell Biology, University College London, Gower Street, London WC1E 6BT, UK., Albrecht D; Medical Research Council-Laboratory for Molecular Cell Biology, University College London, Gower Street, London WC1E 6BT, UK., Burden JJ; Medical Research Council-Laboratory for Molecular Cell Biology, University College London, Gower Street, London WC1E 6BT, UK., Robey RC; Section of Virology, School of Medicine, St Mary's Campus, Imperial College, London W2 1PG, UK., Mercer J; Medical Research Council-Laboratory for Molecular Cell Biology, University College London, Gower Street, London WC1E 6BT, UK., Skinner MA; Section of Virology, School of Medicine, St Mary's Campus, Imperial College, London W2 1PG, UK.

Publikováno v: Biomedicines [Biomedicines] 2020 Dec 19; Vol. 8 (12). Date of Electronic Publication: 2020 Dec 19.